Publication date: May 15, 2019
In 2016, the Centers for Disease Control and Prevention (CDC) released guidelines for medical professionals to follow in an effort to reduce the number of opioid prescriptions; however, the agency is now saying that many doctors may be misapplying these guidelines, to the detriment of patients.
Though not applicable to cancer patients or those in end-of-life or palliative care, the guidelines are broken down into three categories: -The intent of the CDC guidelines was to individualize treatment, but the overly restrictive prescribing policies created by legislatures and payers have led to unintended harm for some patients,” Dr. Kroenke said.
Despite being designed to help prevent overdoses, Dr. Kroenke discovered that many physicians have become too restrictive in their opioid prescriptions and too rigid in following the guidelines, even when the drugs can be helpful to patients.
Dr. Kroenke and his fellow American Academy of Pain Medicine Foundation panelists agree with the basis of the CDC’s guidelines, but they want policymakers to ensure all patients are given the care that is most beneficial to their individual needs going forward.
- CDC concurs with panel led by Regenstrief scientist on misapplication of opioid guidelines
- Doctors welcome CDC’s clarification of opioid prescribing, as guideline authors say it was misapplied
- CDC warns of ‘misapplication’ of its opioid guidelines on chronic pain
- Big Pharma has a Big Role on the Federal Committee Tasked with Curbing Opioid Abuse.
- Industry Voices-Where is PT in the national debate over pain management and opioids?
- CDC Clarifies Position on Use of Opioids in Patients With Cancer
- Defining the opioid crisis, at home and nationwide
- Opioid Crisis Survey: 20% of Patients Face Trouble Obtaining Controlled Substance Prescriptions